α-Klotho (i) may be also a novel biomarker and potential treatment target for diabetic-related complications [34] and (ii) may act as a tumor suppressor and modulator of carcinomas (e.g., hepatocellular and ovarian carcinomas), representing a potential biomarker for their diagnosis [35,36]. Here, KL is linked to ovarian carcinoma.